OAM
XFOR icon

Oxford Asset Management’s X4 Pharmaceuticals XFOR Stock Holding History

Oxford Asset Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-943
Closed -$360K – 2136
2019
Q3 		$360K Sell
943
-3
-0.3% -$1.19K 0.01% 1399
2019
Q2 		$426K Buy
+946
New +$481K 0.01% 1335
2019
Q1 		– Sell
-153
Closed -$64K – 2029
2018
Q4 		$64K Buy
153
+16
+12% +$6.11K ﹤0.01% 1685
2018
Q3 		$43K Buy
+137
New +$58.1K ﹤0.01% 1658

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Oxford Asset Management's XFOR Position: Q4 2019 in Review

Oxford Asset Management sold out of X4 Pharmaceuticals (XFOR) in Q4 2019, closing a stake of 943 shares — an estimated $360K sold.

Oxford Asset Management first reported a position in XFOR in Q3 2018 and held it in 4 quarters. The position peaked at $426K in Q2 2019. 53 funds tracked by Wall St. Rank hold XFOR as of Q4 2019.

  • Oxford Asset Management reported no remaining X4 Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Oxford Asset Management sold 943 X4 Pharmaceuticals shares in Q4 2019, an estimated $360K.
  • Oxford Asset Management first reported a position in X4 Pharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Oxford Asset Management's X4 Pharmaceuticals position peaked at $426K in Q2 2019.
  • 53 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.